GlassScriptPhysician profile
Alexander Johnstone Mackay
NPI 1750813226
$3,136.74
in general payments reported to CMS, 2019-2025
30 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $543 · 2023: $397 · 2024: $885 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,593.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $531.13 | 2022-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Procept Biorobotics Corporation | $316.23 | 2024-2025 | Aquabeam System |
| Endo USA, INC. | $300.85 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $208.83 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $207.62 | 2023-2025 | Jelmyto |
| Janssen Biotech, INC. | $201.30 | 2023-2025 | Erleada, Akeega |
| Axonics, INC. | $189.80 | 2022-2024 | Bulkamid, Axonics |
| Abbvie INC. | $154.99 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $124.92 | 2022-2023 | Aveed, Xiaflex |
| Olympus America INC. | $118.32 | 2024-2025 | Itind System |
| Ethicon US, LLC | $82.54 | 2025 | Vistaseal |
| Sun Pharmaceutical Industries INC. | $75.95 | 2022 | |
| Blue Earth Diagnostics | $61.62 | 2024-2025 | Posluma |
| Laborie Medical Technologies Corp. | $59.13 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $49.92 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.22 | 2024 | Lynparza, Keytruda |
| Coloplast Corp | $43.72 | 2022 | |
| Medtronic, INC. | $38.50 | 2024-2025 | Interstim |
| Pfizer INC. | $38.49 | 2023-2024 | |
| Civco Medical Instruments | $35.55 | 2025 | |
| Dendreon Pharmaceuticals LLC | $34.54 | 2025 | Provenge |
| Becton, Dickinson and Company | $33.41 | 2025 | |
| Astellas Pharma US INC | $31.44 | 2023 | Veozah, Myrbetriq |
| Cycle Pharmaceuticals INC | $29.05 | 2025 | Venxxiva |
| Verity Pharmaceuticals INC. | $27.09 | 2023-2024 | Trelstar |
| Accord Healthcare, INC. | $22.19 | 2025 | |
| Progenics Pharmaceuticals, INC. | $21.77 | 2025 | |
| Urovant Sciences INC | $18.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.67 | 2023 | Seglentis |
| Avation Medical, INC. | $13.18 | 2024 | Vivally |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Mackay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.